Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis

BACKGROUND: Lung cancer is known as the top cancer killer in most developed countries. However, there is currently no promising diagnostic or prognostic biomarker for lung cancer. This study aims to discover non-invasive differential markers in the serum of lung cancer patients, to determine the pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, W C S, Yip, T T, Cheng, W W, Au, J S K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883701/
https://www.ncbi.nlm.nih.gov/pubmed/20502455
http://dx.doi.org/10.1038/sj.bjc.6605700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883701/
https://www.ncbi.nlm.nih.gov/pubmed/20502455
http://dx.doi.org/10.1038/sj.bjc.6605700

Ejemplares similares